Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Recursion in New York is seeking a Clinical Pharmacology Leader to drive innovative strategies for drug development in oncology and rare diseases. You will be responsible for developing clinical strategies, designing studies, and collaborating across various teams to bring therapies to market faster.
The ideal candidate has a Ph.D./M.D. with substantial experience in drug development and proficiency in modeling software. The position offers the potential for remote work while maintaining strong teamwork and commitment to patients’ needs.
You will join an innovative and passionate clinical development team dedicated to improving the lives of patients suffering from devastating diseases. You will lead the innovative clinical pharmacology and pharmacometrics strategy and execution for a portfolio of rare disease and oncology clinical programs.
You will join the Development Sciences team within Recursion comprising clinical pharmacology, pharmacometrics, translational modeling and clinical biomarkers. The Development Sciences group sits within Recursion’s Clinical Development organization. Team members get to sit on both Discovery and Development projects and work in a seamless end-to-end environment at Recursion. The team collaborates closely with clinical development functions (clinical science, clinical operations, regulatory affairs, biostatistics, etc.), as well as discovery functions (DMPK, Biology, Chemistry and Translational Biomarkers).
Experience in oncology is preferred, but not an absolute requirement.
Making SLC or NYC your home base is ideal; however, we will consider remote work for this position. We ask that remote employees commit to regular on‑site visits for routine work and departmental events.
At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is $212,900 to $297,000. You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.
Recursion (NASDAQ: RXRX) is a clinical‑stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI‑native, end‑to‑end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose‑built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter—faster, better, and at scale—for patients who are awaiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.